- Visibility 131 Views
- Downloads 87 Downloads
- Permissions
- DOI 10.18231/.2018.0001
-
CrossMark
- Citation
Comparative study of intralesional BCG and PPD in the treatment of multiple cutaneous warts
- Author Details:
-
Rajashekar T.S.
-
Amulya R
-
Sathish S
-
Suresh Kumar
Introduction: Multiple cutaneous warts are often asymptomatic, cosmetically disfiguring and difficult to treat with conventional modalities, hence immunotherapeutic modalities can be used in such cases. There are no comparitive studies with immunotherapeutic modalities for the treatment of multiple and extensive warts. This study aims to compare the efficacy and safety of intralesional BCG and PPD in the treatment of multiple cutaneous warts.
Materials and Methods: It is a double blinded randomized clinical trial involving thirty patients having more than ten cutaneous warts with a positive mantoux reaction. The patients were randomly allocated into two treatment groups, group A – PPD and group B - BCG. Intralesional injections were given at two weekly intervals till complete clearance of all the warts or for a maximum of four sessions in both the groups. Response in injected warts and distant warts was assessed at each visit and sequential clinical photographic records were maintained.
Results: Thirty patients with positive mantoux reaction were enrolled for the trial, 17 patients in group A (PPD) and 13 patients in group B (BCG). Complete resolution of lesions was noted in 35.3% in PPD group and 30.8% in BCG group and partial resolution was noted in 47.0% and 38.4 % in PPD and BCG group respectively.
Conclusion: Intralesional PPD showed marginally better results than intralesional BCG in the treatment of multiple cutaneous warts. Majority of the patients treated with BCG had tender nodule at injection site.
Keywords: Immunotherapy, Multiple warts, Intralesional BCG, Intralesional PPD.
References
- De Villiers EM Fauquet C, Broker TR, Bernard HU, Zur Hausen H. Classification of papillomaviruses Virology. 2004;324(1):17-27.
- Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev. 2004;68(2):362-72.
- Malejczyk J, Majewski S, Jablonska S. Cellular immunity in cutaneous and genital HPV infections. Clin Dermatol. 1997;15(2):261-74.
- Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE. British Association of D o og ’ g d fo h g of cutaneous warts 2014. Br J Dermatol. 2014;171:696-712.
- Thappa DM, Chiramel MJ. Evolving role of immunotherapy in the treatment of refractory warts. Indian Dermatol Online J. 2016;7:364-70.
- Chandrashekar L. Intralesional immunotherapy for the management of warts. Indian J Dermatol Venereol Leprol. 2011;77:261-3.
- Abd-Elazeim FMA, Mohammed GFA, Fathy A, Mohamed RW. Evaluation of IL-12 serum level in patients with recalcitrant multiple common warts, treated by intralesional tuberculin antigen. J Dermatol Treat. 2014;25:264-7.
- Sharquie KE, Al-Rawi JR, Al-Nuaimy AA, Radhy SH.Bacille Calmette-Guerin immunotherapy of viral warts. Saudi Med J. 2008; 29(7):1068.
- Gupta S, Malhotra AK, Verma KK, Sharma VK. Intralesional immunotherapy with killed Mycobacterium w vaccine for the treatment of ano-genital warts:An open label pilot study. J Eur Acad Dermatol Venereol. 2008;22:1089-93.
- Horn TD, Johnson SM, Helm RM, Roberson PK. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: Asingle- blinded, randomized, and controlled trial. Arch Dermatol. 2005;141:589- 94.
- Arend SM1, Engelhard AC, Groot G, de Boer K, Andersen P, Ottenhoff TH, van Dissel JT. Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact. Clin Diagn Lab Immunol. 2001 Nov;8(6):1089-96.
- Saoji V, Lade NR, Gadegone R, Bhat A. Immunotherapy using purified protein derivative in the treatment of warts: An open uncontrolled trial. Indian J Dermatol Venereol Leprol. 2016;82:42-6.
- Kus S, Ergun T, Gun D, Akin O. Intralesional tuberculin for treatment of refractory warts. J Eur Acad Dermatol Venereol. 2005;19:515-6.
- Elela IM, Elshahid AR, Mosbeh AS. Intradermal vs intralesional purified protein derivatives in treatment of warts. Gulf J Deramatol Venereol. 2011;18:21-6.
- Lahti A, Hannuksela M. Topical immunotherapy with tuberculin jelly for common warts. Arch Dermatol Res. 1982;273:153-4.
- Shaheen MA, Salem SA, Fouad DA, El-Fatah AA. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: A comparative clinical and immunological study. Dermatol Ther. 2015;28:194-200.
- Nimbalkar A, Pande S, Sharma R, Borkar M. Tuberculin purified protein derivative immunotherapy in the treatment of viral warts. Indian J Drugs Dermatol. 2016;2:19-23.
- Daulatabad D, Pandhi D, Singal A. BCG vaccine for immunotherapy in warts: Is it really safe in tuberculosis endemic area?. Dermatol Ther. 2016;29(3):168-72.
- Böhle A, Büttner H, Jocham D. Primary treatment of condylomata acuminata with viable bacillus Calmette- Guerin. J Urol. 2001;165:834-836.
- Böhle A, Doehn C, Kausch I, Jocham D. Treatment of recurrent penile condylomata acuminata with external application and intraurethral instillation of bacillus Calmette-Guerin. J Urol. 1998;160:394-396.
- Metawea BM, Nashar AN, Kamal IK, et al. Application of viable Bacillus Calmette-Guerin topicallly as a potential therapeutic modality in condylomata acuminata. J Urol. 2005;65:247-250.
- Salem A, Nofal A, Hosny D. Treatment of common and plane warts in children with topical viable Bacillus Calmette-Guerin. Pediatr Dermatol. 2013;30:60-63.
- El-Khalawany M, Shaaban D, Aboeldahab S. Immunotherapy of viral warts: myth and reality. Egypt J Dermatol Venerol. 2015;35:1-13
- Kenawi MZ, El-Rahman SHA, Salam OHA. Efficacy of Intralesional 5-Fluorouracil versus BCG Vaccine in the Treatment of Warts. Egypt. J. Derm & Androl. 2012;32(1):3-14.
- Kumar P, Das A. Excellent Response to Intralesional Bacillus Calmette-Guérin Vaccine in a Recalcitrant Periungual Wart. J Cutan Aesthet Surg. 2014;7(4):234-
- Nofal A, Yosef A, Salah E. Treatment of recalcitrant warts with Bacillus - : a promising new approach. Dermatol Ther. 2013;26(6):481-5.
How to Cite This Article
Vancouver
T.S. R, R A, S S, Kumar S. Comparative study of intralesional BCG and PPD in the treatment of multiple cutaneous warts [Internet]. IP Indian J Clin Exp Dermatol. 2018 [cited 2025 Oct 20];4(1):1-6. Available from: https://doi.org/10.18231/.2018.0001
APA
T.S., R., R, A., S, S., Kumar, S. (2018). Comparative study of intralesional BCG and PPD in the treatment of multiple cutaneous warts. IP Indian J Clin Exp Dermatol, 4(1), 1-6. https://doi.org/10.18231/.2018.0001
MLA
T.S., Rajashekar, R, Amulya, S, Sathish, Kumar, Suresh. "Comparative study of intralesional BCG and PPD in the treatment of multiple cutaneous warts." IP Indian J Clin Exp Dermatol, vol. 4, no. 1, 2018, pp. 1-6. https://doi.org/10.18231/.2018.0001
Chicago
T.S., R., R, A., S, S., Kumar, S.. "Comparative study of intralesional BCG and PPD in the treatment of multiple cutaneous warts." IP Indian J Clin Exp Dermatol 4, no. 1 (2018): 1-6. https://doi.org/10.18231/.2018.0001